Syros Pharmaceuticals, Inc (SYRS) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Syros Pharmaceuticals (SYRS) aniq DNA tahlilidan foydalangan holda, onkologik terapiya uchun gen faoliyatini tartibga solishda yuqori darajadagi nufuzga ega. GURU.Markets platformasidagi narxlar dinamikasi 0.00 ko'rsatkichini aks ettirmoqda, shu bilan birga leykozni davolashga bo'lgan talab yuqori darajada qolmoqda. Biznes istiqbollari patent aktivlariga hamda maqsadli tibbiyot sherikliklari doirasidagi tamibarotene sinovlarining kutilayotgan natijalariga bog'liq.
Syros Pharmaceuticals kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Syros Pharmaceuticals|SYRS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati syros.com|SYRS - Kompaniya qarzlari|Balans qiymatiga qarzlar Syros Pharmaceuticals, Inc.|SYRS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Syros Pharmaceuticals|Oraliq qoplash koeffitsiyenti syros.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:SYRS (Syros Pharmaceuticals Inc.)
Ushbu ko'rsatkich kompaniyaning uzoq muddatli majburiyatlarning kapitalga nisbatan bog'liqligini baholaydi. Muddati bir yildan ortiq bo'lgan kreditlarning kapitalga nisbati moliyaviy barqarorlikni va bankrotlik xavfini belgilaydi. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish bozordagi shovqinlarni filtrlash va qarzni boshqarish strategiyasini aniqlash imkonini beradi. Syros Pharmaceuticals uchun qarz yuklamasining pastligi juda muhimdir. Bu tamibarotene ning 3-fazali klinik sinovlari yakunlanguni va FDA tasdig'igacha moliyaviy barqarorlikni ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati GeneDx Holdings WGS|RARE (Ultragenyx Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Beam Tx (BEAM)|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|TWST: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati 10x Genomics (TXG)|NTLA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Stoke STOK|Uzoq muddatli qarzdorlikning kapitalga nisbati BioLife (BLFS)|WVE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti MAZE (mazetx.com)|Sionna Therapeutics (SION) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PRME (Prime Medicine Inc)|TSHA (Taysha) - Uzoq muddatli qarzning kapitalga nisbati|QURE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MGTX|Uzoq muddatli qarzning kapitalga nisbati regenxbio.com (RGNX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Solid Biosciences SLDB|Uzoq muddatli qarzning kapitalga koeffitsiyenti OCGN|PACB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Benitec Corp (BNTC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|DSGN: Uzoq muddatli qarzning kapitalga nisbati|rocketpharma.com (RCKT) - Uzoq muddatli qarzning kapitalga nisbati|FDMT (4D Molecular Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Lexeo (LXEO)|Uzoq muddatli qarzning kapitalga nisbati KRRO|EDIT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Silence Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ProQR PRQR|CDXS: Uzoq muddatli qarzning o'z kapitaliga nisbati|Sangamo Therapeutics Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|NAUT: Uzoq muddatli qarzning kapitalga nisbati|MGX - Uzoq muddatli qarzdorlikning kapitalga nisbati|DTIL (Precision BioSciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Generation Bio Corp (GBIO)|Uzoq muddatli qarzning kapitalga nisbati BOLD|Uzoq muddatli qarzning kapitalga nisbati exicuretx.com (XCUR)|Uzoq muddatli qarzning o'z kapitaliga nisbati Imunon IMNN|Phio Pharmaceuticals Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|MBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TransCode Therapeutics RNAZ|bionanogenomics.com (BNGO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|APDN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BLUE|Uzoq muddatli majburiyatlarning kapitalga nisbati ImmunoPrecise IPA|Uzoq muddatli qarzning o'z kapitaliga nisbati Omega Therapeutics (OMGA)|OMIC (singulargenomics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Regulus Therapeutics Inc. RGLS|Uzoq muddatli qarzdorlikning kapitalga nisbati Telesis Bio Inc. (TBIO)|TRACON - Uzoq muddatli qarzning kapitalga nisbati|UBX (Unity Biotechnology, Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi